ClearPoint Neuro, Inc. (CLPT) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 10.31M USD | Liabilities, Current |
| Cash and equivalents | 29.36M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 8.39M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 8.81M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $10.31M | $29.36M | (m) | $8.39M | $8.81M | (m) |
| 2026-03-31 | (m) | $9.48M | $35.59M | (m) | $8.66M | $8.57M | (m) |
| 2025-12-31 | (m) | $10.77M | $45.92M | (m) | $6.55M | $8.36M | (m) |
| 2025-09-30 | (m) | $8.05M | $38.22M | (m) | $4.00M | $6.58M | (m) |
| 2025-06-30 | (m) | $7.40M | $41.54M | (m) | $4.26M | $6.29M | (m) |
| 2025-03-31 | (m) | $6.87M | $12.39M | (m) | $3.65M | $6.58M | (m) |
| 2024-12-31 | (m) | $10.35M | $20.10M | (m) | $4.71M | $6.86M | (m) |
| 2024-09-30 | (m) | $7.55M | $21.57M | (m) | $3.88M | $7.06M | (m) |
| 2024-06-30 | (m) | $16.69M | $32.84M | (m) | $3.48M | $8.03M | (m) |
| 2024-03-31 | (m) | $15.16M | $35.35M | (m) | $2.51M | $7.96M | (m) |
| 2023-12-31 | (m) | $7.43M | $23.14M | (m) | $3.21M | $7.91M | (m) |
| 2023-09-30 | (m) | $5.59M | $24.34M | (m) | $2.42M | $8.99M | (m) |
| 2023-06-30 | (m) | $6.20M | $26.46M | (m) | $2.80M | $9.20M | (m) |
| 2023-03-31 | (m) | $6.05M | $21.79M | (m) | $2.68M | $9.81M | (m) |
| 2022-12-31 | (m) | $6.79M | $27.61M | (m) | $2.67M | $9.30M | (m) |
| 2022-09-30 | (m) | $6.09M | $18.71M | (m) | $3.41M | $8.28M | (m) |
| 2022-06-30 | (m) | $5.48M | $23.52M | (m) | $3.35M | $6.64M | (m) |
| 2022-03-31 | (m) | $3.97M | $49.66M | (m) | $2.24M | $5.73M | (m) |
| 2021-12-31 | (m) | $4.75M | $54.11M | (m) | $2.34M | $4.94M | (m) |
| 2021-09-30 | (m) | $4.59M | $57.65M | (m) | $2.56M | $3.94M | (m) |
| 2021-06-30 | (m) | $4.38M | $61.52M | (m) | $2.41M | $3.58M | (m) |
| 2021-03-31 | (m) | $3.12M | $64.86M | (m) | $2.00M | $3.27M | (m) |
| 2020-12-31 | (m) | $3.20M | $20.10M | (m) | $1.88M | $3.24M | (m) |
| 2020-09-30 | (m) | $3.71M | $14.67M | (m) | $1.45M | $3.53M | (m) |
| 2020-06-30 | (m) | $3.82M | $16.03M | (m) | $1.16M | $3.60M | (m) |
| 2020-03-31 | (m) | $3.64M | $16.98M | (m) | $984.87K | $3.65M | (m) |
| 2019-12-31 | (m) | $3.83M | $5.70M | (m) | $1.09M | $3.24M | (m) |
| 2019-09-30 | (m) | $4.28M | $6.24M | (m) | $2.13M | $3.18M | (m) |
| 2019-06-30 | (m) | $3.25M | $7.46M | (m) | $1.37M | $2.53M | (m) |
| 2019-03-31 | (m) | $2.27M | $2.49M | (m) | $1.27M | $2.02M | (m) |
| 2018-12-31 | (m) | $2.01M | $3.10M | (m) | $1.23M | $2.11M | (m) |
| 2018-09-30 | (m) | $2.02M | $3.71M | (m) | $1.06M | $2.50M | (m) |
| 2018-06-30 | (m) | $5.95M | $6.70M | (m) | $770.79K | $2.66M | (m) |
| 2018-03-31 | (m) | $5.65M | $7.51M | (m) | $910.11K | $2.53M | (m) |
| 2017-12-31 | (m) | $4.40M | $9.29M | (m) | $949.41K | $2.31M | (m) |
| 2017-09-30 | (m) | $2.65M | $11.03M | (m) | $863.76K | $2.18M | (m) |
| 2017-06-30 | (m) | $2.93M | $12.74M | (m) | $750.76K | $1.89M | (m) |
| 2017-03-31 | (m) | $3.23M | $1.97M | (m) | $1.01M | $1.81M | (m) |
| 2016-12-31 | (m) | $3.02M | $3.32M | (m) | $865.94K | $1.77M | (m) |
| 2016-09-30 | (m) | $3.39M | $4.43M | (m) | $803.54K | $1.80M | (m) |
| 2016-06-30 | (m) | $3.64M | $2.02M | (m) | $769.72K | $1.64M | (m) |
| 2016-03-31 | (m) | $3.23M | $3.58M | (m) | $1.50M | $1.57M | (m) |
| 2015-12-31 | (m) | $7.65M | $5.41M | (m) | $1.22M | $1.81M | (m) |
| 2015-09-30 | (m) | $7.75M | $1.85M | (m) | $837.44K | $1.80M | (m) |
| 2015-06-30 | (m) | $9.48M | $3.52M | (m) | $487.10K | $2.12M | (m) |
| 2015-03-31 | (m) | $5.62M | $6.44M | (m) | $605.72K | $2.10M | (m) |
| 2014-12-31 | (m) | (m) | $9.24M | (m) | $468.95K | $1.97M | (m) |
| 2014-09-30 | (m) | $6.04M | $1.89M | (m) | $548.77K | $2.26M | (m) |
| 2014-06-30 | (m) | $4.75M | $4.08M | (m) | $599.05K | $1.94M | (m) |
| 2014-03-31 | (m) | $5.11M | $5.80M | (m) | $452.70K | $1.66M | (m) |
| 2013-12-31 | (m) | $10.09M | $3.52M | (m) | $770.35K | $1.48M | (m) |
| 2013-09-30 | (m) | $6.31M | $5.03M | (m) | $787.71K | $1.24M | (m) |
| 2013-06-30 | (m) | $5.11M | $6.98M | (m) | $440.70K | $1.20M | (m) |
| 2013-03-31 | (m) | $6.29M | $9.20M | (m) | $384.05K | $1.06M | (m) |
| 2012-12-31 | (m) | $4.18M | $1.62M | (m) | $445.43K | $899.70K | (m) |
| 2012-09-30 | (m) | $6.24M | $3.79M | (m) | $186.05K | $939.74K | (m) |
| 2012-06-30 | (m) | $8.61M | $1.22M | (m) | $169.85K | $939.44K | (m) |
| 2012-03-31 | (m) | $9.69M | $1.68M | (m) | $158.63K | $959.72K | (m) |
| 2011-12-31 | (m) | $14.59M | $145.48K | (m) | $401.58K | $968.82K | (m) |
| 2011-09-30 | (m) | (m) | $70.10K | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | $597.30K | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | $8.86K | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | $1.58M | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $2.57M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |